Literature DB >> 8858963

Agmatinase activity in rat brain: a metabolic pathway for the degradation of agmatine.

M Sastre1, S Regunathan, E Galea, D J Reis.   

Abstract

Agmatinase, the enzyme that hydrolyzes agmatine to form putrescine and urea in lower organisms, was found in rat brain. Agmatinase activity was maximal at pH 8-8.5 and had an apparent K(m) of 5.3 +/- 0.99 mM and a Vmax of 530 +/- 116 nmol/mg of protein/h. After subcellular fractionation, most of the enzyme activity was localized in the mitochondrial matrix (333 +/- 5 nmol/mg of protein/h), where it was enriched compared with the whole-brain homogenate (7.6-11.8 nmol/mg of protein/ h). Within the CNS, the highest activity was found in hypothalamus, a region rich in imidazoline receptors, and the lowest in striatum and cortex. It is interesting that other agmatine-related molecules such as arginine decarboxylase, which synthesizes agmatine, and I2 imidazoline receptors, for which agmatine is an endogenous ligand, are also located in mitochondria. The results show the existence of rat brain agmatinase, mainly located in mitochondria, indicating possible degradation of agmatine by hydrolysis at its sites of action.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858963     DOI: 10.1046/j.1471-4159.1996.67041761.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

Review 1.  Biological significance of agmatine, an endogenous ligand at imidazoline binding sites.

Authors:  W Raasch; U Schäfer; J Chun; P Dominiak
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

Review 2.  Targets of polyamine dysregulation in major depression and suicide: Activity-dependent feedback, excitability, and neurotransmission.

Authors:  Agenor Limon; Firoza Mamdani; Brooke E Hjelm; Marquis P Vawter; Adolfo Sequeira
Journal:  Neurosci Biobehav Rev       Date:  2016-04-22       Impact factor: 8.989

Review 3.  Agmatine: biological role and therapeutic potentials in morphine analgesia and dependence.

Authors:  Soundar Regunathan
Journal:  AAPS J       Date:  2006-07-21       Impact factor: 4.009

4.  Agmatine is transported into liver mitochondria by a specific electrophoretic mechanism.

Authors:  Mauro Salvi; Valentina Battaglia; Mario Mancon; Sebastiano Colombatto; Carlo Cravanzola; Rita Calheiros; Maria P M Marques; Maria A Grillo; Antonio Toninello
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

5.  Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury.

Authors:  C A Fairbanks; K L Schreiber; K L Brewer; C G Yu; L S Stone; K F Kitto; H O Nguyen; B M Grocholski; D W Shoeman; L J Kehl; S Regunathan; D J Reis; R P Yezierski; G L Wilcox
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

6.  Cardiovascular effects of agmatine within the rostral ventrolateral medulla are similar to those of clonidine in anesthetized rats.

Authors:  Jun Yang; Wei-Zhong Wang; Fu-Ming Shen; Ding-Feng Su
Journal:  Exp Brain Res       Date:  2004-10-05       Impact factor: 1.972

7.  Putative agmatinase inhibitor for hypoxic-ischemic new born brain damage.

Authors:  John E Piletz; Stephanie Klenotich; Ken S Lee; Qian Long Zhu; Edward Valente; Michael A Collins; Vyvyca Jones; Soeb Nam Lee; Feng Yangzheng
Journal:  Neurotox Res       Date:  2013-01-19       Impact factor: 3.911

Review 8.  Agmatine : metabolic pathway and spectrum of activity in brain.

Authors:  Angelos Halaris; John Plietz
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

9.  Putrescine biosynthesis in mammalian tissues.

Authors:  Catherine S Coleman; Guirong Hu; Anthony E Pegg
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

10.  Expression, crystallization and preliminary X-ray crystallographic analysis of human agmatinase.

Authors:  Kyoung Hoon Kim; Hyung Jun Ahn; Do Jin Kim; Hyung Ho Lee; Jun-Yong Ha; Hye-Kyung Kim; Hye-Jin Yoon; Se Won Suh
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.